Literature DB >> 8014487

Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990.

L A Lee1, N D Puhr, E K Maloney, N H Bean, R V Tauxe.   

Abstract

To assess factors associated with antimicrobial-resistant Salmonella infections and trends in resistance, a prospective study of patients with culture-confirmed salmonellosis was done in 1989-1990. Patients with resistant infections were more likely than those with susceptible infections to be hospitalized (P = .006), to be < 1 year old (P = .003), to be black (P = .013), and to have recently been treated with an antimicrobial agent (P = .085). Compared with data from a similar study in 1979-1980, increases were seen in the percentage of patients with resistant infections (from 17% to 31%), in the resistance to ampicillin (10% to 14%), and in the frequency of isolates found in blood (1% to 11%). These data show that treatment of Salmonella infections may be complicated by growing resistance to clinically important antimicrobial agents and by an increasing frequency of extraintestinal complications. Antimicrobial agents with little demonstrated resistance should be considered for patients with complicated illness and at high risk of having a resistant infection.

Entities:  

Mesh:

Year:  1994        PMID: 8014487     DOI: 10.1093/infdis/170.1.128

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

1.  Prevalence and antimicrobial susceptibility of serogroup D nontyphoidal Salmonella in a university hospital in Taiwan.

Authors:  Cheng-Hsun Chiu; Lin-Hui Su; Ching-Chi Hung; Kuo-Lung Chen; Chishih Chu
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Antimicrobial Resistance in Salmonella in the United States from 1948 to 1995.

Authors:  Daniel A Tadesse; Aparna Singh; Shaohua Zhao; Mary Bartholomew; Niketta Womack; Sherry Ayers; Patricia I Fields; Patrick F McDermott
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

3.  Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.

Authors:  P L Winokur; A Brueggemann; D L DeSalvo; L Hoffmann; M D Apley; E K Uhlenhopp; M A Pfaller; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Changes in susceptibility of Salmonella enteritidis, Salmonella typhimurium, and Salmonella virchow to six antimicrobial agents in a Spanish hospital, 1980-1994.

Authors:  J M Ramos; J M Alés; M Cuenca-Estrella; R Fernández-Roblas; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

Review 5.  Epidemiology, control and treatment of multiresistant gram-negative rods.

Authors:  B Wiedemann
Journal:  Drugs       Date:  1996       Impact factor: 9.546

6.  Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.

Authors:  Sheng Chen; Shenghui Cui; Patrick F McDermott; Shaohua Zhao; David G White; Ian Paulsen; Jianghong Meng
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

7.  Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium.

Authors:  Morten Helms; Pernille Vastrup; Peter Gerner-Smidt; Kåre Mølbak
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

8.  Salmonella enterica serotype Typhimurium DT104 isolated from humans, United States, 1985, 1990, and 1995.

Authors:  Efrain M Ribot; Rachel K Wierzba; Frederick J Angulo; Timothy J Barrett
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

9.  Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria.

Authors:  G G Khachatourians
Journal:  CMAJ       Date:  1998-11-03       Impact factor: 8.262

10.  International spread of multidrug-resistant Salmonella Schwarzengrund in food products.

Authors:  Frank M Aarestrup; Rene S Hendriksen; Jana Lockett; Katie Gay; Kathryn Teates; Patrick F McDermott; David G White; Henrik Hasman; Gitte Sørensen; Aroon Bangtrakulnonth; Srirat Pornreongwong; Chaiwat Pulsrikarn; Frederick J Angulo; Peter Gerner-Smidt
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.